CD69 and metabolic dysfunction-associated steatotic liver disease: Overall, the NAFLD patients showed a higher percentage of CD69 cells than the controls, and we found significant differences in Th22, Thf, Th2, Tregs, and Th9 activation both in patients with and without MCI (Figure 2B).